Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vipoglanstat in Moderate to Severe Endometriosis-related Pain
NCT07260669Phase 2Active, not recruiting
- Sponsor
- Gesynta Pharma
- Start
- Oct 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of vipoglanstat in endometriosis, sponsored by Gesynta Pharma. Started Oct 2025; status: active, not recruiting.
02
Drugs
vipoglanstat
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT07260669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07260669.